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Abstract
Background: Primary bone lymphomas (PBL) are extremely rare malignant neoplasms. The most commonly
described subtype of PBL is diffuse large B-cell lymphoma (DLBCL). DLBCL within peri-prosthetic membrane of a
joint is exceedingly rare. To the best of our knowledge this case is the second reported Epstein-Bar-Virus (EBV)
negative DLBCL in a peri-prosthetic membrane in the literature.
Case presentation: We report an 80 year old female patient who developed a DLBCL with chronic inflammation in
association to a metallic implant in the left knee. This lymphoma in contrast to the usually described DLBCL in the peri-
prosthetic membrane was EBV negative by EBER in situ hybridization as well as by polymerase chain reaction (PCR).
Conclusion: This report challenges the concept of DLBCL associated with chronic inflammation and raises the
question of other pathogenetic factors involved in the pathogenesis of this rare disease.
Keywords: Primary bone lymphoma, Diffuse large B-cell lymphoma, Epstein-Barr-Virus negative, Knee arthroplasty, Peri-
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HBx, HBV-encoded X-protein; NGS, Next generation sequencing; NHL, Non-Hodgkin Lymphoma; PBL, Primary bone
lymphoma; PCR, Polymerase chain reaction; WHO, World Health Organization
Background
Lymphoma is the seventh most common systemic malig-
nancy worldwide [1, 2]. DLBCL is the most common ag-
gressive Non-Hodgkin Lymphoma (NHL) [3] and in
addition the most common type of PBL [4]. Over the
last decades, the use of joint replacement surgery, such
as total hip and total knee arthroplasty, has increased
[2]. Despite this fact lymphomas developed within the
peri-prosthetic membrane are exceedingly rare. These
lymphomas may be observed in a context of chronic in-
flammation with EBV, which seems to play a central role
in disease development. Since 2008 this entity has been
included in the World Health Organization (WHO)
classification of Haematopoietic and Lymphoid Tissues
as “DLBCL associated with chronic inflammation” [1, 5].
Case presentation
In 2004 a 69 year old woman underwent total left knee
replacement with a cemented knee endoprosthesis for
osteoarthritis. In February 2015 a loosening of the pros-
thesis was diagnosed radiologically (Fig. 1) in association
with a rupture of the collateral ligament.
The patient underwent replacement of the prosthesis in
August 2015 with ASA 4 (American Society of
Anesthesiology Classification) because of multiple comor-
bidities. The listed comorbidities included adipositas, dia-
betes mellitus, high blood pressure, hyperlipidaemia and
coronary heart disease. In addition the patient showed in
clinical chemistry positivity for HBVc (Hepatitis B Virus
core) antibody but negativity for Hepatitis B by PCR.
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The peri-prosthetic membrane was removed and a
new prosthesis was implanted without complications.
The peri-prosthetic membrane was sent to the Institute
of Pathology to exclude infection. The histological exam-
ination showed infiltration by a DLBCL. Clinically the
patient showed no signs of generalization.
A chemotherapy with (R-)-mini-CHOP (with 50 % of
Cyclophospamid, Doxorubicin and Oncovin) was
started. Because of the positivity of HBVc antibody the
Mabthera therapy started in the 2nd cycle after confirm-
ation of negative Hepatitis B PCR. After chemotherapy
she received a total irradiation dose 40 Gy with conven-
tional fractions.
At a follow-up of 8 months the patient did not show
any sign of recurrence.
Results
The specimen sent for histological examination mea-
sured 2:1,5:0,8 cm and revealed grey-white tissue.
The histolologic examination showed connective tissue
with massive hyalinization and sclerosis with a centrally,
circumscribed, nodular infiltration of large lymphoid
cells (Fig. 2a). The predominant cellular component con-
sisted of blasts, with round and notched nuclei with
clear chromatin and multiple nucleoli (Fig. 2b). The mi-
totic activity was high with 4 mitoses per high power
field. Between the blasts a few polymorphic small react-
ive lymphocytes were present. The blasts showed strong
expression of CD 20, CD 79a (Fig. 2c), CD20 (Fig. 2d),
PAX 5 and bcl-2 by immunohistochemistry.
Only a small subset of blasts demonstrated a positive
staining with CD 30 and bcl-6 (<5 %). Staining for EBER
(in situ hybridisation for EBV with INFORM EBER) and
CD 15 were negative. In addition the atypical B-cell
Fig. 2 a HE stained section shows connective tissue with massive
hyalinization and sclerosis and skeletal muscle with a centrally,
circumscribed, nodular infiltration of large lymphoid cells. b The
predominant cellular component consisted of blasts, with round and
notched nuclei with clear chromatin and multiple nucleoli. c In the
immunohistochemistry staining the blasts reveal an expression of
CD 79a. d In the immunohistochemistry staining the blasts reveal an
expression of CD 20
Fig. 1 Radiography of the left knee shows a loosening of the prosthesis
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population did not express CD10, MUM1, GCET1,
CD33, myeloperoxidase, C-MYC, CD117c and FOXP1.
The proliferation index (MIB) was 80 %.
The diagnosis of a DLBCL was supported by perform-
ing a PCR, demonstrating a gene rearrangement in the
immunoglobulin heavy chain gene with a monoclonal
peak at 243 bp and an immunoglobulin light chain gene
rearrangement with a monoclonal cell population kappa
A at 288 bp.
EBV was additionally excluded by a PCR using Light-
cycler analysis.
Performing a Low Density Whole Genome Copy
Number Variation with next generation sequencing
(NGS) we could not detect any copy number variation.
Furthermore mutational analysis of the full coding se-
quence of the TP 53 gene did not demonstrate muta-
tions in TP 53.
Discussion
Primary lymphoma of the bone is rare, accounting for
3–7 % of malignant bone neoplasms and 4–5 % of extra-
nodal Non-Hodgkin lymphomas [6]. Primary Non-
Hodgkin lymphomas arising in the peri-prosthetic mem-
brane around metallic implants are extremely rare. The
carcinogenic effects of the metallic components and
wear particles are not yet fully elucidated [7]. Most cases
reported in this context are DLBCL associated with
chronic inflammation and concomitant EBV infection
[2, 7]. Campo et al. report, that in these lesions
lymphomas-infected cells frequently express a latency
type 3 with positivity for the viral proteins latent mem-
brane protein 1 and EBV nuclear antigen 2, suggesting,
that the lymphoid proliferation may be related primarily
to a decrease in the host immune-surveillance [5]. Our
described case of DLBCL, however, lacks EBV infection
and is localized to the knee without any other site of in-
volvement. A summary of our literature search (see
Table 1) showed only one case of diffuse large B-cell
lymphoma in association with a joint replacement with-
out EBV association and was published in 2011 [2]. An-
other case was reported with negativity for the EBV in
situ hybridization, but positivity for EBV in the polymer-
ase chain reaction [7]. All reported cases did not show
any signs of generalization [2, 7–13].
In the context of our case we would like to challenge
the concept that “DLBCL associated with chronic in-
flammation” is always associated with EBV infection. In
our case EBV could clearly not be demonstrated by
otherwise classic features of “DLBCL associated with
chronic inflammation”. Although the pathogenesis in our
case is not fully elucidated, we hypothesize that other fac-
tors may play a role in this context. Especially metallic
ions are known to have carcinogenic potential. After a
metal implantation a significant increased concentration
of cobalt and chromium in the synovial fluid and blood
could be measured. These metallic ions have mutagenic
effects and have been described to potentially predispose
to lymphomas [2]. In 2004 Landon et al. report about an
increase in chromium and cobalt levels, an increased inci-
dence of chromosomal translocation and an aneuploidy in
the peripheral blood of patients within 2 years after metal-
on-metal joint arthroplasty [14].
In addition a higher level of HBVc antibody was in-
cidentally found in our patient. Gross et al. states that
Table 1 Shows a summary of presented cases in the literature including our recent case
Journal Age/Sex Localisation Latency Diagnosis EBV status
Our case 80 female Left knee 11 years DLBCL EBERinsitu -PCR -
Acta Haematol.
2011;126(3):141–6. [2]
76 male Right Tibia 3 years DLBCL EBERinsitu -
Am J Surg Pathol 2005;
29: 832–836. [8]
78 male Right knee 22 years DLBCL EBV IHC + EBERinsitu +
Journal of Clinical Oncology,
Vol 31, 2013: pp e148-e151. [7]
69 male Left knee 3 years DLBCL EBERinsitu - PCR +
Arch Orthop Trauma Surg
2008; 128: 1387–1390. [9]
70 female Left knee About a half year DLBCL not available
J Arthroplasty. 2001
Feb;16(2):229–32. [10]





75 female Right tigh 13 years Malignant immunoblastic
lymphoma
not available
J Clin Pathol. 1998
Aug; 51(8): 629–632. [12]
63 female Left tigh 4 years Diffuse centroblastic
lymphoma
not available





48 male Left tibia 17 years Malignant lymphoma not available
Sunitsch et al. Diagnostic Pathology  (2016) 11:80 Page 3 of 5
a negative HBV DNA does not rule out an HBV
infection [15].
In the literature a connection between Hepatitis B
virus infection and Non-Hodgkin lymphomas is de-
scribed [16–21]. It is suggested that HBV is not only a
hepatotropic but also a lymphotropic disease and partici-
pates in the development of malignant lymphoprolifera-
tive disorders. For viral clearance the cellular and
humoral immunity plays an important role for HBV
infection and disease progression. The cellular and
humoral immunity system gets activated after HBV in-
fection. The immune system destroys the HBV infected
cells and the host cells, which are infected by HBV [18].
However, the mechanisms are not fully elucidated [19,
20] and several theories are suggested. Proposed theories
include [19]:
(a)Chronic stimulation of B-cells is the problem for
DNA damage and transformation into B- cell NHL.
(b)Chronic local antigenic stimulation could be
associated with a development of lymphoma.
(c)HBV-encoded X-protein (HBx) inhibits p53 in hepa-
tocytes and this mechanism causes hepatocellular
carcinoma. The inhibition of p53 in B-cells may
cause malignant transformation into a NHL. How-
ever this theory can be excluded by performing mu-
tational analysis covering the whole coding sequence
of TP53.
(d)The infection of epithelial cells might serve as a
trigger for expression, production or release of
hematopoietic tumor growth factor.
(e)A coinfection with another unknown virus is
suggested to cause lymphoma.
Conclusion
We report a case of an 80 year old woman, who developed
an EBV negative DLBCL in the peri-prosthetic membrane
11 years after total knee arthroplasty. The presented case
demonstrates that EBV infection might not be obligatory
in DLBCL associated with chronic inflammation. This re-
port challenges the concept of DLBCL associated with
chronic inflammation and raises the question of other
pathogenetic factors involved in the pathogenesis of this
rare disease.
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